Drug Type Chemical drugs |
Synonyms GC 373, GC373 |
Target |
Mechanism SARS-CoV 3CLpro inhibitors(SARS-CoV-2-3C-like-proteinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H29N3O5 |
InChIKeyQYENXTYKACLCGO-FQECFTEESA-N |
CAS Registry1333231-44-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Virus Diseases | Preclinical | US | 12 Aug 2012 | |
COVID-19 | Discovery | US | 27 Aug 2020 | |
Norovirus Infections | Discovery | US | 15 Sep 2011 |